Semler Scientific, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Semler Scientific reports a 45% revenue drop in its core healthcare business, offset by significant Bitcoin fair value gains, alongside a pending merger and major legal settlements.
Semler Scientific reported a significant increase in second-quarter net income driven by Bitcoin fair value gains, despite a sharp decline in healthcare revenues and a substantial litigation settlement charge.
10-Q: Semler Scientific Reports Q1 2025 Results, Impacted by CMS Rate Changes and Bitcoin Volatility
Semler Scientific's Q1 2025 results reveal a net loss driven by decreased revenues due to CMS rate changes and a significant decrease in the fair value of bitcoin holdings.
Semler Scientific's Q3 2024 results show a decrease in revenue compared to the previous year, alongside a strategic move to adopt Bitcoin as its primary treasury reserve asset.
Semler Scientific's Q2 2024 results show a decrease in revenue and a net income of $11,000, impacted by pricing changes and a new bitcoin treasury strategy.
Semler Scientific's first quarter 2024 results show a decrease in revenue but an increase in net income compared to the same period last year.